Xeris Pharmaceuticals | Kostnadene For Salg



Cost Of Sales Endring Dato
Adcock Ingram Holdings ZAR 3.29B 163.08M 2024-06
Celltrion KRW 418.52B 88.39B 2024-09
Cspc Pharmaceutical CNY 2.07B 71.26M 2024-09
Ecofibre AUD 5.55M 761K 2024-06
Eli Lilly USD 2.4B 233M 2024-12
Kangmei Pharma CNY 1.21B 124.7M 2024-09
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 152.05M 84.2M 2024-12
Malin Corporation EUR 15.4M 0 2020-12
Medical Developments International AUD 2.35M 1.73M 2024-06
Organigram Holdings CAD 41.68M 69.31M 2024-12
Pacira USD 39.89M 1.02M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Pharma Mar EUR 1.31M 696K 2024-12
Qiagen NV USD 187.91M 16.67M 2024-12
Sartorius EUR 448.5M 23.9M 2024-09
Sino Biopharmaceutical CNY 2.49B 1.07B 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Tilray USD 149.73M 9.39M 2024-11
Zz Pientze Pharmaceu 1.49B 37.2M 2024-09



Xeris Pharmaceuticals Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.